Respiratory Viruses in Adults With Community-Acquired Pneumonia
Identifieur interne : 000D54 ( Main/Curation ); précédent : 000D53; suivant : 000D55Respiratory Viruses in Adults With Community-Acquired Pneumonia
Auteurs : David Lieberman [Israël] ; Avi Shimoni [Israël] ; Yonat Shemer-Avni [Israël] ; Ayelet Keren-Naos [Israël] ; Rachel Shtainberg [Israël] ; Devora Lieberman [Israël]Source :
- Chest : (American College of Chest Physicians) [ 0012-3692 ] ; 2010.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Adulte.
English descriptors
- KwdEn :
Abstract
Background: Use of nucleic acid amplification techniques has increased the identification of respiratory viruses (RVs) in adult patients with community-acquired pneumonia (CAP). The objectives of the present study were to identify RV in patients with CAP using three different sampling methods and to compare CAP virus proportions and types with two comparison groups. Methods: The study population included 183 adult patients with CAP, 450 control subjects, and 201 patients with nonpneumonic lower respiratory tract infection (NPLRTI). Each participant was sampled by oropharyngeal swab, nasopharyngeal swab, and nasopharyngeal washing, and the samples were tested for detection of 12 RVs by multiplex TaqMan Hydrolysis probe-based real-time polymerase chain reaction (Integrated DNA Technology; Coralville, IA). Results: At least one RV was identified in 58 patients with CAP (31.7%) compared with 32 (7.1%) in control subjects and 104 (51.7%) in patients with NPLRTI (P < .01 and P < .01, respectively). Corona-viruses were identified in 24 (13.1%) patients with CAP, compared with 17 (3.8%) in control subjects, and 21 (10.4%) patients with NPLRTI. Respiratory syncytial virus was identified in 13 (7.1%), four (0.9%), and seven (3.5%); rhinovirus in nine (4.9%), nine (2.0%), and 15 (7.5%); and influenza virus in eight (4.4%), two (0.4%), and 63 (31.3%) patients with CAP, control subjects, and patients with NPLRTI, respectively. Conclusions: The proportion of RV involvement in CAP is higher than previously reported. The proportion of RV identified in healthy subjects is significantly lower than in CAP, but it is not zero and should be weighed when interpreting corresponding proportions among patients.
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000016
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000043
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000015
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :000D56
Links to Exploration step
Pascal:10-0485663Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Respiratory Viruses in Adults With Community-Acquired Pneumonia</title>
<author><name sortKey="Lieberman, David" sort="Lieberman, David" uniqKey="Lieberman D" first="David" last="Lieberman">David Lieberman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pulmonary Unit, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shimoni, Avi" sort="Shimoni, Avi" uniqKey="Shimoni A" first="Avi" last="Shimoni">Avi Shimoni</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shemer Avni, Yonat" sort="Shemer Avni, Yonat" uniqKey="Shemer Avni Y" first="Yonat" last="Shemer-Avni">Yonat Shemer-Avni</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pulmonary Unit, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Keren Naos, Ayelet" sort="Keren Naos, Ayelet" uniqKey="Keren Naos A" first="Ayelet" last="Keren-Naos">Ayelet Keren-Naos</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shtainberg, Rachel" sort="Shtainberg, Rachel" uniqKey="Shtainberg R" first="Rachel" last="Shtainberg">Rachel Shtainberg</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lieberman, Devora" sort="Lieberman, Devora" uniqKey="Lieberman D" first="Devora" last="Lieberman">Devora Lieberman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Geriatric Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0485663</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0485663 INIST</idno>
<idno type="RBID">Pascal:10-0485663</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000016</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000043</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000015</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000015</idno>
<idno type="wicri:doubleKey">0012-3692:2010:Lieberman D:respiratory:viruses:in</idno>
<idno type="wicri:Area/Main/Merge">000D56</idno>
<idno type="wicri:Area/Main/Curation">000D54</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Respiratory Viruses in Adults With Community-Acquired Pneumonia</title>
<author><name sortKey="Lieberman, David" sort="Lieberman, David" uniqKey="Lieberman D" first="David" last="Lieberman">David Lieberman</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pulmonary Unit, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shimoni, Avi" sort="Shimoni, Avi" uniqKey="Shimoni A" first="Avi" last="Shimoni">Avi Shimoni</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shemer Avni, Yonat" sort="Shemer Avni, Yonat" uniqKey="Shemer Avni Y" first="Yonat" last="Shemer-Avni">Yonat Shemer-Avni</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pulmonary Unit, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Keren Naos, Ayelet" sort="Keren Naos, Ayelet" uniqKey="Keren Naos A" first="Ayelet" last="Keren-Naos">Ayelet Keren-Naos</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shtainberg, Rachel" sort="Shtainberg, Rachel" uniqKey="Shtainberg R" first="Rachel" last="Shtainberg">Rachel Shtainberg</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Virology Laboratory, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lieberman, Devora" sort="Lieberman, Devora" uniqKey="Lieberman D" first="Devora" last="Lieberman">Devora Lieberman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Division of Internal Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Geriatric Medicine, Soroka Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev</s1>
<s2>Beer-Sheva</s2>
<s3>ISR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Israël</country>
<wicri:noRegion>Beer-Sheva</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Chest : (American College of Chest Physicians)</title>
<title level="j" type="abbreviated">Chest : (Amer. Coll. Chest Phys.)</title>
<idno type="ISSN">0012-3692</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Chest : (American College of Chest Physicians)</title>
<title level="j" type="abbreviated">Chest : (Amer. Coll. Chest Phys.)</title>
<idno type="ISSN">0012-3692</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Anesthesia</term>
<term>Cardiology</term>
<term>Circulatory system</term>
<term>Community acquired infection</term>
<term>Pneumonia</term>
<term>Respiratory tract</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Pneumonie</term>
<term>Infection communautaire</term>
<term>Voie respiratoire</term>
<term>Adulte</term>
<term>Anesthésie</term>
<term>Appareil circulatoire</term>
<term>Cardiologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Use of nucleic acid amplification techniques has increased the identification of respiratory viruses (RVs) in adult patients with community-acquired pneumonia (CAP). The objectives of the present study were to identify RV in patients with CAP using three different sampling methods and to compare CAP virus proportions and types with two comparison groups. Methods: The study population included 183 adult patients with CAP, 450 control subjects, and 201 patients with nonpneumonic lower respiratory tract infection (NPLRTI). Each participant was sampled by oropharyngeal swab, nasopharyngeal swab, and nasopharyngeal washing, and the samples were tested for detection of 12 RVs by multiplex TaqMan Hydrolysis probe-based real-time polymerase chain reaction (Integrated DNA Technology; Coralville, IA). Results: At least one RV was identified in 58 patients with CAP (31.7%) compared with 32 (7.1%) in control subjects and 104 (51.7%) in patients with NPLRTI (P < .01 and P < .01, respectively). Corona-viruses were identified in 24 (13.1%) patients with CAP, compared with 17 (3.8%) in control subjects, and 21 (10.4%) patients with NPLRTI. Respiratory syncytial virus was identified in 13 (7.1%), four (0.9%), and seven (3.5%); rhinovirus in nine (4.9%), nine (2.0%), and 15 (7.5%); and influenza virus in eight (4.4%), two (0.4%), and 63 (31.3%) patients with CAP, control subjects, and patients with NPLRTI, respectively. Conclusions: The proportion of RV involvement in CAP is higher than previously reported. The proportion of RV identified in healthy subjects is significantly lower than in CAP, but it is not zero and should be weighed when interpreting corresponding proportions among patients.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D54 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000D54 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV1 |flux= Main |étape= Curation |type= RBID |clé= Pascal:10-0485663 |texte= Respiratory Viruses in Adults With Community-Acquired Pneumonia }}
This area was generated with Dilib version V0.6.33. |